Use of Tapered Balloons to Recanalize Occluded Below-the-Knee Arteries in Diabetic Patients with Critical Limb Ischemia

医学 严重肢体缺血 缺血 肢体缺血 心脏病学 内科学 外科 解剖 动脉疾病 血管疾病
作者
Nicola Troisi,Leonardo Ercolini,Emiliano Chisci,Piefrancesco Frosini,Clara Pigozzi,Enrico Barbanti,Eugenio Romano,Stefano Michelagnoli
出处
期刊:Annals of Vascular Surgery [Elsevier BV]
卷期号:31: 105-110 被引量:4
标识
DOI:10.1016/j.avsg.2015.08.015
摘要

The aim of this study was to evaluate the outcome of tapered balloon use in recanalization of long occlusions of below-the-knee (BTK) arteries in diabetic patients with critical limb ischemia (CLI).Forty-nine occluded BTK arteries in 35 diabetic patients with CLI were revascularized in our Diabetic Foot Center between January and September 2014 using tapered balloons. Twelve-month outcomes were evaluated in terms of healing of the lesions, survival, limb salvage, primary patency, primary assisted patency, and secondary patency.The patients were predominantly male (27/35, 77.1%) with a mean age of 70.9 years (±10.3 standard deviation [SD]). During the follow-up (mean duration 12.4 months ± 4 SD), healing of the lesions was obtained in 27 of the 35 cases (77.1%). Estimated 12-month survival and limb salvage were 85.7% and 91.1%, respectively. Estimated 12-month primary patency, primary assisted patency, and secondary patency were 78.3%, 79%, and 88.9%, respectively. Univariate analysis demonstrated that the presence of chronic renal failure affected survival (P = 0.005), and assignment to Rutherford class 6 affected limb salvage (P = 0.005), primary patency (P < 0.001), and primary assisted patency (P < 0.001). Furthermore, the presence of coronary artery disease affected primary patency (P = 0.001) and primary assisted patency (P = 0.05).Tapered balloons are a safe and effective means to recanalize long occlusions of BTK arteries in diabetic patients with CLI. Outcomes are poorer in patients with major tissue loss and with a history of coronary artery disease. Further experience with larger groups is needed to validate these outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
三水发布了新的文献求助10
2秒前
NexusExplorer应助Zorn采纳,获得10
3秒前
111完成签到,获得积分10
3秒前
111发布了新的文献求助10
5秒前
5秒前
5秒前
在水一方应助小巧的砖家采纳,获得10
6秒前
动听服饰完成签到,获得积分10
6秒前
Lucas应助顾长生采纳,获得10
6秒前
7秒前
8秒前
感谢有你完成签到,获得积分10
9秒前
万能图书馆应助moika采纳,获得10
10秒前
NexusExplorer应助莉莉拉贝采纳,获得10
14秒前
meteorwithyou发布了新的文献求助10
15秒前
西伯侯完成签到,获得积分10
15秒前
16秒前
18秒前
李健的粉丝团团长应助Www采纳,获得10
19秒前
彭于晏应助Zxc采纳,获得30
20秒前
20秒前
所所应助蓝02333采纳,获得10
21秒前
21秒前
21秒前
21秒前
22秒前
22秒前
22秒前
23秒前
孩他妈完成签到,获得积分10
23秒前
24秒前
tao发布了新的文献求助10
24秒前
25秒前
CodeCraft应助粗暴的镜子采纳,获得10
25秒前
26秒前
虚心的渊思完成签到,获得积分10
26秒前
Shawn发布了新的文献求助10
27秒前
Alaiiif应助宋万里采纳,获得10
27秒前
传奇3应助宋万里采纳,获得10
27秒前
拾柒发布了新的文献求助10
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
Electrode Potentials 550
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6961163
求助须知:如何正确求助?哪些是违规求助? 8643795
关于积分的说明 18330815
捐赠科研通 6410402
什么是DOI,文献DOI怎么找? 3085929
关于科研通互助平台的介绍 2134454
邀请新用户注册赠送积分活动 2062393